Secondary amyloidosis complication of Crohn disease treated with infliximab / 영남의대학술지
Yeungnam University Journal of Medicine
; : 102-105, 2015.
Article
在 Ko
| WPRIM
| ID: wpr-213788
Responsible library:
WPRO
ABSTRACT
Secondary systemic (AA) amyloidosis is a severe complication of progressed Crohn disease (CD) characterized by the deposition of amyloid A in body organs and tissues. Various therapeutic approaches have been recommended, however there is still no effective treatment. Recently, several case reports have demonstrated the effects of anti-tumor necrosis factor-alpha therapy in patients with AA amyloidosis associated with CD. We report on a 35-year-old female patient with CD complicated by AA amyloidosis in the gastrointestinal tract and renal involvement, who was treated with infliximab. The infliximab therapy improved the gastrointestinal symptoms and decreased the serum creatinine.
Key words